tiprankstipranks
Trending News
More News >
Koken Ltd. (JP:7963)
:7963
Japanese Market
Advertisement

Koken Ltd. (7963) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7963

Koken Ltd.

(7963)

Rating:75Outperform
Price Target:
¥1,932.00
▲(6.10% Upside)
Koken Ltd. demonstrates strong financial performance with stable revenue growth and robust margins. The technical analysis shows positive momentum, supported by favorable moving averages and a positive MACD. The valuation is attractive with a low P/E ratio and a reasonable dividend yield. These factors collectively contribute to a solid overall stock score, despite the absence of recent earnings call data and corporate events.

Koken Ltd. (7963) vs. iShares MSCI Japan ETF (EWJ)

Koken Ltd. Business Overview & Revenue Model

Company DescriptionKoken Ltd. (7963) is a Japan-based company primarily engaged in the manufacture and sale of automotive service equipment. The company specializes in the production of wrenches, sockets, and other tools essential for automotive maintenance and repair. Koken Ltd. is known for its high-quality, durable products that cater to both professional mechanics and automotive enthusiasts.
How the Company Makes MoneyKoken Ltd. generates revenue through the sale of its automotive service tools and equipment. Its core revenue stream comes from direct sales to automotive repair shops, dealerships, and tool distributors. The company benefits from a strong brand reputation for quality and reliability, which helps in maintaining a steady customer base. Additionally, Koken Ltd. may engage in strategic partnerships with automotive manufacturers or distributors to expand its market reach. Export sales also contribute to its earnings, allowing the company to tap into international markets where there is demand for premium automotive tools.

Koken Ltd. Financial Statement Overview

Summary
Koken Ltd. exhibits solid financial health with consistent revenue growth and strong gross margins. The balance sheet is robust with a healthy equity ratio and manageable debt levels. Cash flow generation is stable, though there was a notable decline in free cash flow in the latest period. Overall, the company is well-positioned financially, with opportunities to enhance profitability and cash flow efficiency.
Income Statement
85
Very Positive
Koken Ltd. has demonstrated stable revenue growth with a 1.65% increase in 2024 compared to 2023. The gross profit margin stands at 45.74%, indicating strong profitability. However, the net profit margin is 6.71%, which is moderate. The EBIT margin of 9.38% and EBITDA margin of 13.86% reflect efficient operations, though there is room for improvement in net profitability.
Balance Sheet
78
Positive
The company's balance sheet shows a solid equity position with an equity ratio of 62.47%. The debt-to-equity ratio is 0.40, indicating a manageable level of leverage. Return on equity is 5.54%, which suggests moderate efficiency in generating returns from shareholders' equity. Overall, the balance sheet is stable, but there is potential to enhance returns.
Cash Flow
72
Positive
Koken Ltd. experienced a decline in free cash flow by 49.79% in 2024. The operating cash flow to net income ratio is 0.92, indicating that operating cash flow is closely aligned with net income. The free cash flow to net income ratio is 0.62, showing that a significant portion of net income is converted into free cash flow. Despite the decline in free cash flow, cash flow generation remains relatively strong.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue11.17B10.76B10.59B10.60B10.20B10.15B
Gross Profit5.13B4.92B4.84B4.99B4.65B4.89B
EBITDA1.60B1.49B1.51B1.80B1.88B1.69B
Net Income826.57M722.06M701.13M833.11M862.37M837.66M
Balance Sheet
Total Assets21.55B20.87B20.82B20.57B19.60B19.00B
Cash, Cash Equivalents and Short-Term Investments3.78B2.53B2.98B2.39B2.19B1.56B
Total Debt5.92B5.18B6.05B6.13B6.13B5.95B
Total Liabilities8.39B7.83B8.46B8.75B8.49B8.54B
Stockholders Equity13.16B13.04B12.35B11.82B11.11B10.47B
Cash Flow
Free Cash Flow0.00445.38M886.94M451.74M417.31M709.59M
Operating Cash Flow0.00666.37M1.08B618.95M655.48M1.37B
Investing Cash Flow0.00-98.81M-206.25M-184.20M147.58M-606.28M
Financing Cash Flow0.00-1.05B-307.82M-291.98M-176.25M-680.15M

Koken Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1821.00
Price Trends
50DMA
1720.76
Positive
100DMA
1677.81
Positive
200DMA
1618.65
Positive
Market Momentum
MACD
22.64
Negative
RSI
77.48
Negative
STOCH
94.72
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7963, the sentiment is Positive. The current price of 1821 is above the 20-day moving average (MA) of 1732.05, above the 50-day MA of 1720.76, and above the 200-day MA of 1618.65, indicating a bullish trend. The MACD of 22.64 indicates Negative momentum. The RSI at 77.48 is Negative, neither overbought nor oversold. The STOCH value of 94.72 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7963.

Koken Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥32.23B10.76
2.44%7.99%28.81%
78
Outperform
¥8.96B12.00
3.76%3.38%88.65%
75
Outperform
¥8.84B11.26
1.92%9.07%43.42%
74
Outperform
¥16.92B16.31
3.43%-8.07%-38.21%
73
Outperform
¥273.87B20.01
1.88%4.43%-1.39%
56
Neutral
¥13.80B10.23
2.86%4.84%-148.94%
51
Neutral
$7.85B-0.18-40.01%2.28%22.97%-2.05%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7963
Koken Ltd.
1,821.00
302.18
19.90%
JP:5187
Create Medic Co., Ltd.
985.00
51.50
5.52%
JP:6678
Techno Medica Co., Ltd.
1,988.00
174.04
9.59%
JP:6823
Rion Co., Ltd.
2,614.00
510.34
24.26%
JP:6849
Nihon Kohden Corporation
1,648.50
-294.23
-15.15%
JP:7600
Japan Medical Dynamic Marketing, Inc.
520.00
-218.44
-29.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 28, 2025